The immune response in individuals with HLA-DR specificities conferring susceptibility to insulin-dependent diabetes--a hypothesis.
D000917:Antibody Formation; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases; D001402:B-Lymphocytes / Q000276:immunology*; D003429:Cross Reactions; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D004198:Disease Susceptibility; D000939:Epitopes; D005802:Genes, MHC Class II; D006684:HLA-DR Antigens; D006238:Haploidy; D000949:Histocompatibility Antigens Class II; D006801:Humans; D007111:Immunity, Cellular; D007515:Islets of Langerhans / Q000276:immunology; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology
D001323:Autoantibodies; D000939:Epitopes; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II